PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0
Wolfgang P. Fendler(German Society of Surgery), Matthias Eiber(TUM Klinikum), Mohsen Beheshti(Paracelsus Medical University), Jamshed Bomanji, Jérémie Calais(University of California, Los Angeles), Francesco Ceci(University of Milan), Steve Y. Cho(University of Wisconsin–Madison), Stefano Fanti(Istituto delle Scienze Neurologiche di Bologna), Frederik L. Giesel(Heidelberg University), Karolien Goffin(KU Leuven), Uwe Haberkorn(Heidelberg University), Heather A. Jacene(Brigham and Women's Hospital), Phillip J. Koo(Banner MD Anderson Cancer Center), Klaus Kopka(Helmholtz-Zentrum Dresden-Rossendorf), Bernd J. Krause(University of Rostock), Liza Lindenberg(National Cancer Institute), Charles Marcus(Emory University), Felix M. Mottaghy(Maastricht University), Daniela E. Oprea‐Lager(Amsterdam University Medical Centers), Joseph R. Osborne(Cornell University), Morand Piert(University of Michigan), Steven P. Rowe(Johns Hopkins University), Heiko Schöder(Memorial Sloan Kettering Cancer Center), Simon Wan, Hans‐Jürgen Wester(Technical University of Munich), Thomas A. Hope(University of California, San Francisco), Ken Herrmann(Essen University Hospital)
Cited by 353Open Access
Abstract
Here we aim to provide updated guidance and standards for the indication, acquisition, and interpretation of PSMA PET/CT for prostate cancer imaging. Procedures and characteristics are reported for a variety of available PSMA small radioligands. Different scenarios for the clinical use of PSMA-ligand PET/CT are discussed. This document provides clinicians and technicians with the best available evidence, to support the implementation of PSMA PET/CT imaging in research and routine practice.
Related Papers
No related papers found
Powered by citation graph analysis